This study aimed to evaluate the dosimetric benefits of magnetic resonance (MR)-guided radiotherapy (MRgRT) compared to computed tomography (CT)-guided RT for partial breast treatment. First, treatmen
sheet "doses": tumor dose distributions obtained from 90Y TOF-PET post selective internal radio-nuclide therapy (SIRT) and total lesion metabolism (TLM) variation measured using 11C-acetate or 18F-FDG